Search

everythinglearnresearchcommunity

for

Search:↓

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Abrocitinib may effectively treat Lichen Planopilaris.

Lactiplantibacillus plantarum ZJUIDS51 can help regrow hair and improve scalp health in androgenic alopecia.

Leptin, a hormone, is important for starting hair growth.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Prostaglandin treatments for glaucoma can cause rare eye area changes like eyelid deepening and fat pad prolapse.

Prolactin slows down hair growth in mice.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Droplet-based microfluidics improves delivery of bioactive compounds in food using precise encapsulation and release.

Thymic stromal lymphopoietin (TSLP) promotes hair growth by stimulating specific skin cells.

Targeting LPA could help treat skin disorders.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

New treatments targeting insulin, blood flow, and inflammation could improve hormone-related hair conditions with fewer side effects.

Glutamic acid microneedle patches promote better hair growth than traditional treatments.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

New treatments show promise for hair loss, especially JAK inhibitors for alopecia areata.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Early diagnosis, genetic testing, and innovative treatments are crucial for managing complex medical conditions.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Finasteride and baicalin in phospholipid vesicles effectively promote hair growth and increase follicle count.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Spanlastic-laden nanogel could be a better way to deliver hair growth medication through the skin for treating hair loss.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.